ClinicalTrials.gov
ClinicalTrials.gov Menu

ASA404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Treating Patients With Refractory Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01031212
Recruitment Status : Withdrawn (The investigator has left the institution (UCSF) prior to study start-up)
First Posted : December 14, 2009
Last Update Posted : May 13, 2013
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by:
University of California, San Francisco

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : June 2012
  Estimated Study Completion Date : June 2013